TRADE WITH CONVICTION

Saturday, August 29, 2026
RSS



IPO
Hecate Energy Advances Toward Nasdaq Listing Under Planned Ticker HCTE After Lender Disputes

Hecate Energy and EGH Acquisition Corp. report progress toward a planned Nasdaq listing under $HCTE after resolving lend…

James McAllister • Aug 28, 2026
IPO
Bunker Hill and Silver47’s $163 Million Merger Targets US Silver and Critical Minerals Demand

Bunker Hill and Silver47 propose a $163 million all-stock merger, linking US and Canadian listings around a US-focused s…

Marcus Rivera • Aug 22, 2026
IPO
Bunker Hill, Silver47 Set $163 Million All-Stock Merger to Build U.S. Silver Platform

Bunker Hill and Silver47 announced a $163 million all-stock merger, creating a proposed U.S. silver and critical-mineral…

Sarah Chen • Aug 21, 2026
IPO
Bunker Hill and Silver47 Plan Cross-Border Merger to Build a 'Made in America' Silver Champion

Bunker Hill and Silver47 have signed a definitive merger agreement aimed at creating a U.S. silver and critical-minerals…

Marcus Rivera • Aug 21, 2026
IPO
Francisco Partners’ $7.40 Weave Offer Sets a Deal-Driven Price Test for WEAV

Francisco Partners has agreed to buy Weave Communications for $7.40 a share in cash, creating a potential merger-arbitra…

Marcus Rivera • Aug 18, 2026
IPO
Brookfield and La Caisse Complete Boralex Takeover, Removing TSX Renewable-Energy Stock

Boralex’s removal from the TSX narrows Canada’s listed clean-energy universe and highlights institutional demand for ren…

Sarah Chen • Aug 15, 2026
IPO
Mobix Labs’ Rare Earths Deal Puts MOBX at the Center of a National Security Pivot

Mobix Labs’ proposed Special Project Delivery acquisition would shift MOBX toward rare earths, critical minerals, energy…

Sarah Chen • Aug 13, 2026
IPO
Goldman Sachs’ $2.25 Billion NEOS Deal Signals a Bigger Push Into Options-Based ETFs

Goldman Sachs’ agreement to acquire NEOS for up to $2.25 billion expands its asset-management reach into options-overlay…

Sarah Chen • Aug 12, 2026
IPO
Tarsus to Acquire Alkeus, Adding Phase 3 Stargardt Disease Drug Candidate

Tarsus is acquiring Alkeus and its Phase 3 Stargardt disease candidate ALK-001, while Harrow’s TYRVAYA deal highlights o…

Marcus Rivera • Aug 6, 2026
IPO
SpaceX Faces First Post-IPO Earnings Test as Analyst Sees Potential for 3x Stock Move

SpaceX’s first post-IPO earnings report could set its early valuation narrative as traders weigh a bullish analyst view …

James McAllister • Aug 4, 2026
IPO
Four Corners Property Trust's Latest Acquisition: Insights for Investors

FCPT's acquisition of a Burger King property signals growth in net-lease investments, appealing to income-focused invest…

Catherine Walsh • Jul 21, 2026
IPO
Freenome's IPO: A New Contender in Cancer Detection

Freenome's IPO marks a significant step in blood-based cancer detection, reshaping the landscape for biotech investors.

Catherine Walsh • Jul 21, 2026